GLENMARK
Invest with MTF
Invest Now
Invest in Glenmark Pharmaceuticals with 3.43X leverage
Performance
- Low
- ₹1,941
- High
- ₹1,980
- 52 Week Low
- ₹1,276
- 52 Week High
- ₹2,285
- Open Price₹1,958
- Previous Close₹1,935
- Volume399,133
- 50 DMA₹1,974.69
- 100 DMA₹1,948.92
- 200 DMA₹1,861.72
Investment Returns
- Over 1 Month -5.07%
- Over 3 Month + 8.99%
- Over 6 Month -2.24%
- Over 1 Year + 28.2%
Smart Investing Starts Here Start SIP with Glenmark Pharmaceuticals for Steady Growth!
Glenmark Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 52.3
- PEG Ratio
- 0.1
- Market Cap Cr
- 55,718
- P/B Ratio
- 5.8
- Average True Range
- 58.19
- EPS
- 95.92
- Dividend Yield
- 0.3
- MACD Signal
- -8.15
- RSI
- 49.44
- MFI
- 32.11
Glenmark Pharmaceuticals Financials
Glenmark Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,974.40
+
39.6
(2.05%)
- Bearish Moving Average 7
- Bullish Moving Average 9
- 20 Day
- ₹1,975.15
- 50 Day
- ₹1,974.69
- 100 Day
- ₹1,948.92
- 200 Day
- ₹1,861.72
Resistance and Support
1965.23
- R3 2,027.57
- R2 2,003.73
- R1 1,989.07
- S1 1,950.57
- S2 1,926.73
- S3 1,912.07
Glenmark Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Glenmark Pharmaceuticals F&O
About Glenmark Pharmaceuticals
- NSE Symbol
- GLENMARK
- BSE Symbol
- 532296
- Chairman & Managing Director
- Mr. Glenn Saldanha
- ISIN
- INE935A01035
Similar Stocks to Glenmark Pharmaceuticals
Glenmark Pharmaceuticals FAQs
Glenmark Pharmaceuticals share price is ₹1,974 As on 10 February, 2026 | 00:45
The Market Cap of Glenmark Pharmaceuticals is ₹55717.7 Cr As on 10 February, 2026 | 00:45
The P/E ratio of Glenmark Pharmaceuticals is 52.3 As on 10 February, 2026 | 00:45
The PB ratio of Glenmark Pharmaceuticals is 5.8 As on 10 February, 2026 | 00:45
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.